6640--FY26| Thyroid Cancer Molecular Test| Orlando VA & San Juan| New Requirement
Veterans Affairs · 248-NETWORK CONTRACT OFFICE 8 (36C248)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C24826Q0337 in this department, oldest first.
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Decide bid or no bid before the response deadline.
- Look at the past winners for likely competitors and teaming partners.
- Follow the opportunity to hear about amendments and the award.
What the notice says
The Caribbean VA Healthcare System and Orlando VA Healthcare System intends to solicit and award an acquisition for Thyroid Cancer Molecular Test, as defined in the Statement of Work (SOW). This will be a Base of 12-months and Four (4) 12-month options. This requirement is solicited as Unrestricted. The Primary North American Industry Classification System (NAICS) for this acquisition is 621511 Medical Laboratories, with a related small business size standard of $41.5 Million, and FSC/PSC is 6640. This solicitation is a Request for Quote (RFQ), for a Firm-Fixed Price (FFP) requirement contract… (show all)
, which will be advertised as unrestricted on or before 26 February 2026, via sam.gov website. The solicitation and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2025-06 10/01/2025. To be eligible for award, prospective offerors must be registered in the System for Award Management (SAM) Internet site, www.sam.gov. Amendments to the RFQ will be posted to this website only. It is the responsibility of the quoter to review the web page for notice of amendments, updates, or changes to the solicitation. No hard copies will be mailed. The contractor must ensure that we receive the proposal on time; NO late proposals will be accepted/ considered. Any questions or concerns regarding this solicitation should be submitted no later than 03/02/2026 at 12:00 PM EST. No further questions will be accepted after that date and time. Please submit questions in writing via e-mail to the Contract Specialist, Yolanda Glover, at yolanda.glover@va.gov. All quotations for this solicitation shall be submitted no later than 03/09/2026 at 4:00 PM EST. Please submit all responses to the Contract Specialist, Yolanda Glover, at yolanda.glover@va.gov Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(c). *Note* To prepare / complete a Quote, See Offerors Checklist under 52.212-2 Evaluation Commercial Items.
Who won similar work
8 award notices on SAM.gov in the last 24 months. Matched by: Same office (248-NETWORK CONTRACT OFFICE 8 (36C248)), same product/service code (PSC) 6640.
Single-winner award sizes (8): middle half $491K to $3.5M, median $1.7M; range $83K to $31.8M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC | 2 | $4.2M | Apr 16, 2026 |
| CEPHEID SUNNYVALE 94089 | 2 | $843K | Oct 5, 2026 |
| BIOMERIEUX INC | 1 | $31.8M | Jan 21, 2025 |
| SEBIA, INC. | 1 | $3.6M | May 4, 2026 |
| Fisher Scientific Company · $TMO · $46.3B | 1 | $2.7M | Mar 31, 2026 |
| FRANKLIN YOUNG INTERNATIONAL, INCORPORATED | 1 | $83K | Oct 1, 2025 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $TMO reported $46.3B revenue (12 months to Jun 27, 2026). The median single-winner award in these 8 past awards, $1.7M, is under 0.1% of that. SEC filing
One award's total value against one year of revenue; many awards are paid over several years.
- Oct 5, 2026CEPHEID SUNNYVALE 94089$561K6640--FY27 Cepheid - Base Plus 4 Option Years (VA-27-00000309)No listed company matched (Materiality N/A)
- May 4, 2026SEBIA, INC.$3.6M6640--VISN 8 Electrophoresis TestingNo listed company matched (Materiality N/A)
- Apr 16, 2026POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC$3.5M6640--VISN 8 Mail FIT KitsNo listed company matched (Materiality N/A)
- Mar 31, 2026Fisher Scientific Company$2.7M6640--Allergy and Autoimmune Disease (TAM and BP)Materiality: <0.01% of $TMO revenue (Low) SEC
- Oct 1, 2025FRANKLIN YOUNG INTERNATIONAL, INCORPORATED$83K6640--JAK2 Molecular ReagentsNo listed company matched (Materiality N/A)
- May 9, 2025POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC$666K6640--FY25: Automated Immunochemical Fecal Occult Blood Test (IFOBT)No listed company matched (Materiality N/A)
- Apr 2, 2025CEPHEID SUNNYVALE 94089$282K6640--FY25 Q3 Micro Molecular Testing (VA-25-00029953)No listed company matched (Materiality N/A)
- Jan 21, 2025BIOMERIEUX INC$31.8M6640--FY25: VISN 8 Molecular Pathogen DetectionNo listed company matched (Materiality N/A)
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 6 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 2 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (7 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- $40K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Veterans' Affairs, Senate Committee on Appropriations, Senate Committee on Veterans' Affairs
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 7 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 1 of the past winners are listed companies
- 0 insider buys and 7 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.